$1.6
+0.13
(+8.84%)▲
Insights on Ocean Biomedical Inc
In the last 1 year, Novo Nordisk A/s has given 72.6% return, outperforming this stock by 143.5%
9.38%
Downside
Day's Volatility :17.14%
Upside
8.57%
67.5%
Downside
52 Weeks Volatility :93.47%
Upside
79.9%
Period | Ocean Biomedical Inc | Index (Russel 2000) |
---|---|---|
3 Months | -60.78% | 0.0% |
6 Months | 95.26% | 0.0% |
1 Year | -71.07% | 0.0% |
3 Years | -73.47% | -22.6% |
Market Capitalization | 54.4M |
Book Value | - $2.21 |
Earnings Per Share (EPS) | -3.0 |
Wall Street Target Price | 18.5 |
Profit Margin | 0.0% |
Operating Margin TTM | 0.0% |
Return On Assets TTM | -681.99% |
Return On Equity TTM | 0.0% |
Revenue TTM | 0.0 |
Revenue Per Share TTM | 0.0 |
Quarterly Revenue Growth YOY | 0.0% |
Gross Profit TTM | 0.0 |
Diluted Eps TTM | -3.0 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | 0.0 |
EPS Estimate Next Year | 0.0 |
EPS Estimate Current Quarter | 0.0 |
EPS Estimate Next Quarter | 0.0 |
What analysts predicted
Upside of 1056.25%
Sell
Neutral
Buy
Ocean Biomedical Inc is currently in a neutral trading position according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Ocean Biomedical Inc | 14.7% | 95.26% | -71.07% | -73.47% | -73.47% |
Moderna, Inc. | 21.03% | 85.08% | 14.68% | -28.27% | 659.22% |
Regeneron Pharmaceuticals, Inc. | 3.22% | 20.18% | 31.88% | 93.3% | 227.58% |
Novo Nordisk A/s | 8.85% | 34.38% | 71.83% | 235.07% | 463.44% |
Vertex Pharmaceuticals Incorporated | 16.81% | 34.1% | 40.6% | 123.97% | 174.53% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Ocean Biomedical Inc | NA | NA | NA | 0.0 | 0.0 | -6.82 | NA | -2.21 |
Moderna, Inc. | 24.73 | NA | 0.0 | -7.14 | -0.38 | -0.16 | NA | 33.47 |
Regeneron Pharmaceuticals, Inc. | 28.89 | 28.89 | 1.46 | 44.13 | 0.15 | 0.08 | NA | 250.15 |
Novo Nordisk A/s | 46.97 | 46.97 | 2.36 | 3.5 | 1.0 | 0.25 | 0.01 | 22.18 |
Vertex Pharmaceuticals Incorporated | 29.59 | 29.59 | 0.53 | 17.08 | 0.24 | 0.13 | NA | 71.8 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Ocean Biomedical Inc | Buy | $54.4M | -73.47% | NA | 0.0% |
Moderna, Inc. | Buy | $54.6B | 659.22% | 24.73 | -115.82% |
Regeneron Pharmaceuticals, Inc. | Buy | $108.0B | 227.58% | 28.89 | 29.45% |
Novo Nordisk A/s | Buy | $602.6B | 463.44% | 46.97 | 36.55% |
Vertex Pharmaceuticals Incorporated | Buy | $117.5B | 174.53% | 29.59 | 39.46% |
Organization | Ocean Biomedical Inc |
Employees | 0 |
CEO | Ms. Elizabeth Ng M.B.A. |
Industry | Miscellaneous |
A Spac I Acquisition Corp
$1.60
+8.84%
Keyarch Acquisition Corp
$1.60
+8.84%
Connexa Sports Technologies Inc
$1.60
+8.84%
Us Value Etf
$1.60
+8.84%
First Wave Biopharma Inc
$1.60
+8.84%
Global X Msci Next Emerging
$1.60
+8.84%
Fat Projects Acquisition Corp
$1.60
+8.84%
Capital Link Global Fintech
$1.60
+8.84%
Applied Uv Inc
$1.60
+8.84%